NEW YORK August 4, 2025 Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1 Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate
That is a 90 percent price reduction
In a 2023 clinical study conducted by a research team led by Dr
From detailed hormonal assessments to customized dietary and lifestyle plans, they provide the support and guidance necessary to achieve balance and wellness
When combined, these two treatments form a powerful protocol to maintain facial integrity without an overdone look
Its imperative that we pay for health care services that help members without adding excessive costs that impact the affordability of health coverage for all members and customer groups
